0329 Biomea Fusion
BioCentury & Getty Images


Launched by Pharmacyclics vets, preclinical cancer start-up Biomea Fusion seeks short path to IPO

Menin inhibitor moving toward clinic three months after series A

As its moves a menin inhibitor toward the clinic, Biomea has filed to go public three months after its series A round.

Mar 28, 2021 | 11:52 AM GMT

Less than

Read the full 588 word article

How to gain access

Continue reading with a
two-week free trial.